McKesson, Clayton Dubilier & Rice in talks to acquire Option Care Health for $5B
Summary
McKesson is in advanced negotiations with private equity firm Clayton Dubilier & Rice to acquire Option Care Health in a deal valued at $5 billion, including debt, according to reports from the Financial Times. This move comes amid a broader trend where private equity firms are enhancing their healthcare investments by appointing executives with expertise to better identify and evaluate opportunities within the sector.
Tokens
$MCK
Analysis
McKesson: McKesson Corporation is a leading healthcare company focused on pharmaceutical distribution, supply chain services, and related technology solutions. It is currently in advanced talks with Clayton Dubilier & Rice to acquire Option Care Health, underscoring its strategy to expand capabilities in home and alternate site care. Clayton Dubilier & Rice: Clayton Dubilier & Rice is a private equity firm that invests across sectors with a notable presence in healthcare. The firm has recently added healthcare operating advisers to support deal sourcing and is partnering with McKesson on the potential acquisition of Option Care Health. Healthcare Investments: Private equity firms are actively building healthcare expertise through executive appointments to identify and evaluate opportunities in the sector. Strategic Partnerships: Healthcare distribution companies are extending long-term agreements with major pharmacy chains to strengthen supply chain relationships.
Categories
macro
Related sources
- https://stockanalysis.com/stocks/opch/transcripts/658117-q2-2026/
- https://www.cdr.com/news?sectors=healthcare
- https://markets.ft.com/data/announce/detail?dockey=600-202610010803BIZWIRE_USPRX____20261001_BW569834-1
- https://www.fool.com/earnings/call-transcripts/2026/02/24/option-care-opch-earnings-call-transcript/
- https://www.sec.gov/Archives/edgar/data/1014739/000110465926002887/tm262606d1_ex99-2.htm
- https://news.bloomberglaw.com/private-equity/cd-r-taps-former-bristol-myers-ceo-caforio-in-healthcare-push
- https://www.cdr-inc.com/news
- https://www.mckesson.com/about-us/newsroom/press-releases/
- https://pharmaphorum.com/tag/clayton-dubilier-rice
- https://www.bloomberg.com/news/articles/2026-09-09/cd-r-taps-former-bristol-myers-ceo-caforio-in-healthcare-push
- https://www.marketscreener.com/news/mckesson-corporation-extends-pharmaceutical-distribution-agreement-with-cvs-health-ce785ddadb88f320
- https://news.alphastreet.com/option-care-health-inc-opch-q3-2025-earnings-call-transcript/
- https://www.morningstar.com/stocks/xnys/mck/quote
- https://stocklight.com/stocks/us/nasdaq-opch/option-care-health/annual-reports/nasdaq-opch-2026-10K-26671478.pdf
- https://www.mckesson.com/about-us/newsroom/